CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
Walking therapy with Exo-H2 exoskeletondevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03477123
NCT03477123N/ACompleted
CompareCT.gov

Evaluation of Robotic Exoskeletons Therapy for Gait Rehabilitation in Patients With Incomplete Spinal Cord Injury

Hospital Nacional de Parapléjicos de Toledo·interventional·Posted Mar 26, 2018·Updated Jul 7, 2020

In Brief

A clinical study evaluating Walking therapy with Exo-H2 exoskeleton for Spinal Cord Injury and Incomplete Spinal Cord Injury. Completed, enrolled 20 participants across 1 site.

Detailed Summary

The objective of the study is to assess the efficacy of the Exo-H2 robotic exoskeleton for walking rehabilitation of people with incomplete spinal cord injury.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSpinal Cord Injury, Incomplete Spinal Cord Injury
CountriesSpain
CollaboratorsInstitut Guttmann

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedMar 26, 2018
Enrollment StartJan 1, 2016
Primary CompletionMar 31, 2020
Study CompletionJul 3, 2020
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 8.3 years ago

Interventions

Walking therapy with Exo-H2 exoskeletondevice